Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...

A confirmed H1N1 outbreak has hit Anum Senior High School, with all nine samples from the school testing positive.

Nine students of Anum Senior High School in the Asuogyaman District of the Eastern Region have tested positive for the H1N1 ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

Most people do not know the difference between a cold and a flu, and with all this jargon of Swine Flu/Covid/Virus, we are left to fend for ourselves to figure out what exactly we have, a common cold ...

If regulators approve the flu vaccine, the company can then advance the ... The mRNA-1010 jab also demonstrated strong efficacy for each of the major influenza strains in the shot, including A/H1N1, A ...

The CDC's vaccine advisory committee voted to recommend annual flu vaccines but against flu shots containing the preservative thimerosal ...